Alteration of central serotonin modifies onset and severity of adjuvant-induced arthritis in the rat

British Journal of Rheumatology

Volumn 37, Issue 10, 1998, Pages 1077-1083

  Harbuz, M S ^a   Marti, O ^a   Lightman, S L ^a   Jessop, D S ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Adjuvant induced arthritis; Corticosterone; Corticotrophin releasing factor; Inflammation; Pro opiomelanocortin; Serotonin; SSRI

Indexed keywords

5,7 DIHYDROXYTRYPTAMINE; ADJUVANT; NEUROTOXIN; SEROTONIN; SEROTONIN UPTAKE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; BLOOD SAMPLING; BRAIN TISSUE; CONTROLLED STUDY; HYPOPHYSIS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOTHESIS; INFLAMMATION; MALE; NONHUMAN; PLETHYSMOGRAPHY; PRIORITY JOURNAL; RAT; SEROTONIN RELEASE;

5,7-DIHYDROXYTRYPTAMINE; ANIMALS; ARTHRITIS, EXPERIMENTAL; BRAIN; CORTICOSTERONE; CORTICOTROPIN-RELEASING HORMONE; EDEMA; HINDLIMB; HYDROXYINDOLEACETIC ACID; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; PITUITARY-ADRENAL SYSTEM; PRO-OPIOMELANOCORTIN; RATS; RNA, MESSENGER; SEROTONIN; SEROTONIN ANTAGONISTS; SEROTONIN UPTAKE INHIBITORS;

EID: 0031752769     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Maling HM, Webster ME, Williams MA et al. Inflammation induced by histamine, serotonin, bradykinin and compound 48/80 in the rat: antagonists and mechanisms of action. J Pharmacol Exp Ther 1974;191:300-10.
2. Holsapple MP, Scnur M, Yim GKW. Pharmacological modulation of edema mediated by prostaglandin, serotonin and histamine. Agents Actions 1980;10:368-73.
3. Sufka KJ, Schomburg FM, Giordano J. Receptor mediation of 5-HT-induced inflammation and nociception in rats. Pharmacol Biochem Behav 1991;41:53-6.
4. Wang JP, Hsu MF, Raung SL et al. Suppressive effect of 2-phenyl-4-quinolone (YT-1) on hind paw edema and cutaneous vascular plasma extravasation in mice. Naumyn Schmiedebergs Arch Pharmacol 1994;349: 324-30.
5. Sofia RD, Vassar HB. Changes in serotonin (5HT) concentrations in brain tissue of rats with adjuvant-induced polyarthritis. Arch Int Pharmacodyn 1974; 211:74-9.
6. Weil-Fugazza J, Godefroy F, Besson JM. Changes in brain and spinal tryptophan and 5-hydroxyindoleacetic acid levels following acute morphine administration in normal and arthritic rats. Brain Res 1979;175:291-301.
7. Godefroy F, Weil-Fugazza J, Besson J-M. Complex temporal changes in 5-hydroxytryptamine synthesis in the central nervous system induced by experimental polyarthritis in the rat. Pain 1987;28:223-38.
8. Garzon J, Lerida M, Sanchez-Blazquez P. Effect of intrathecal injection of pertussis toxin on substance P, norepinephrine and serotonin contents in various neural structures of arthritic rats. Life Sci 1990;47:1915-23.
9. Marlier L, Poulat P, Rajaofetra N et al. Modifications of serotonin-, substance P- and calcitonin gene-related peptide-like immunoreactivities in the dorsal horn of the spinal cord of arthritic rats: a quantitative immunocytochemical study. Exp Brain Res 1991;85:482-90.
10. Pertsch M, Krause E, Hirschelmann R. A comparison of serotonin (5-HT) blood levels and activity of 5-HT2 antagonists in adjuvant arthritic Lewis and Wistar rats. Agents Actions 1993;38:C98-101.
11. Schoenen J, Van Hees J, Gybels J et al. Histochemical changes of substance P, FRAP, serotonin and succinic dehydrogenase in the spinal cord of rats with adjuvant arthritis. Life Sci 1985;36:1247-54.
12. Harbuz MS, Perveen-Gill Z, Lalies MD et al. The role of endogenous serotonin in adjuvant-induced arthritis. Br J Rheumatol 1996;35:112-6.
13. Sternberg EM, Young WS, Bernardini R et al. A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with the susceptibility to streptococcal cell wall-induced arthritis in Lewis rats. Proc Natl Acad Sci USA 1989;86:4771-5.
14. Mason D. Genetic variation in the stress response: susceptibility to experimental allergic encephalomyelitis and implications for human inflammatory disease. Immunol Today 1991;12:57-60.
15. Harbuz MS, Rees RG, Eckland D et al. Paradoxical responses of hypothalamic CRF mRNA and CRF-41 peptide and adenohypophyseal POMC mRNA during chronic inflammatory stress. Endocrinology 1992;130: 1394-400.
16. Brady LS, Page SW, Thomas FS et al. l'l-Ethylidenebis[L-tryptophan], a contaminant implicated in L-tryptophan eosinophilia myalgia syndrome, suppresses mRNA expression of hypothalamic corticotropin-releasing hormone in Lewis (LEW/N) rat brain. Neuroimmunomodulation 1994;1:59-65.
17. Chowdrey HS, Larsen PJ, Harbuz MS et al. Evidence for arginine vasopressin as the primary activator of the HPA axis during adjuvant-induced arthritis. Br J Pharmacol 1995;116:2417-24.
18. Harbuz MS, Rees RG, Lightman SL. HPA axis responses to acute stress and adrenalectomy during adjuvant-induced arthritis in the rat. Am J Physiol 1993; 264:R179-85.
19. MacPhee IA, Antoni FA, Mason DW. Spontaneous recovery of rats from experimental allergic encephalomyelitis is dependent on regulation of the immune system by endogenous adrenal corticosteroids. J Exp Med 1989;169:431-5.
20. Young WS III, Mezey E, Siegel RE. Quantitative in situ hybridization histochemistry reveals increased levels of corticotropin-releasing factor mRNA after adrenalectomy in rats. Neurosci Lett 1986;70:198-203.
21. Harbuz MS, Lightman SL. Responses of hypothalamic and pituitary mRNA to physical and psychological stress in the rat. J Endocrinol 1989;122:705-11.
22. Harbuz MS, Chalmers J, De Souza L et al. Stress-induced activation of CRF and c-fos mRNAs in the paraventricular nucleus are not affected by serotonin depletion. Brain Res 1993;609:167-73.
23. Harbuz MS, Leonard JP, Lightman SL et al. Changes in hypothalamic corticotrophin releasing factor (CRF) and pituitary proopiomelanocortin (POMC) messenger RNA during the course of experimental allergic encephalomyelitis (EAE). J Neuroimmunol 1993;45:127-32.
24. Palkovits M, Brownstein MJ. Maps and guide to micro-dissection of the rat brain. New York: Elsevier, 1988.
25. Renner K, Luine V. Analysis of temporal and dose-dependent effects of estrogens on monoamines in brain nuclei. Brain Res 1986;366:64-71.
26. Hansen HH, Sanchez C, Meier E. Neonatal administration of the selective serotonin reuptake inhibitor Lu 10-134-C increases forced swimming-induced immobility in adult rats: A putative animal model of depression. J Pharmacol Exp Ther 1997;283:1333-41.
27. Stanford SC. Prozac: panacea or puzzle? Trends Pharm Sci 1996;17:150-4.
28. Bhattacharya SK, Das N. Central serotoninergic modulation of carageenan-induced pedal inflammation in rats. Pharm Res 1985;85:315-8.
29. Grubb BD, McQueen DS, Iggo A et al. A study of 5HT-receptors associated with afferent nerves located in normal and inflamed rat ankle joints. Agents Actions 1988;25:216-8.
30. Pierce PA, Xie G-X, Peroutka SJ et al. 5-hydroxytryptamine-induced synovial plasma extravasation is mediated via 5-hydroxytryptamine 2A receptors on sympathetic efferent terminals. J Pharmacol Exp Ther 1995;275:502-8.
31. Sternberg EM, Hill JM, Chrousos GP et al. Inflammation mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis susceptible Lewis rats. Proc Natl Acad Sci USA 1989;86:2374-8.
32. Holmes MC, French KL, Seckl JR. Modulation of serotonin and corticosteroid receptor gene expression in the rat hippocampus with circadian rhythm and stress. Mol Brain Res 1995;28:186-92.
33. Pousset F, Fournier J, Legoux P et al. Effect of serotonin on cytokine mRNA expression in rat hippocampal astrocytes. Mol Brain Res 1996;38:54-62.
34. Zalcman S, Green-Johnson JM, Murray LNDM et al. Cytokine specific central monoamine alterations induced by interleukin-1, -2, and -6. Brain Res 1994;643:40-9.
35. Linthorst ACE, Flachskamm C, Holsboer F et al. Local administration of recombinant human interleukin 1-beta in the rat hippocampus increases serotonergic neurotransmission, hypothalamic-pituitary-adrenocortical axis activity, and body temperature. Endocrinology 1994; 135:520-32.
36. Linthorst ACE, Flachskamm C, Muller-Preuss P et al. Effect of bacterial endotoxin and interleukin 1-beta on hippocampal serotonergic neurotransmission, behavioural activity and free corticosterone levels: an in vivo microdialysis study. J Neurosci 1995;15:2920-34.
37. Linthorst ACE, Flachskamm C, Holsboer F et al. Activation of serotonergic and noradrenergic neurotransmission in the rat hippocampus after peripheral administration of bacterial endotoxin: involvement of the cyclo-oxygenase pathway. Neuroscience 1996;72: 989-97.
38. Conde GL, Renshaw D, Lightman SL et al. Serotonin depletion does not alter lipopolysaccharide-induced activation of the rat paraventricular nucleus. J Endocrinol 1998;156:245-51.
39. Hollt V, Przewlocki R, Haarman I et al. Stress-induced alterations in the levels of messenger RNA coding for proopiomelanocortin and prolactin in rat pituitary. Neuroendocrinology 1986;43:277-82.
40. Stephanou A, Sarlis NJ, Knight RA et al. Response of pituitary and spleen POMC mRNA and spleen and thymus interleukin-1β mRNA to adjuvant arthritis. J Neuroimmunol 1992;37:59-63.
41. Bertini R, Bianchi M, Ghezzi P. Adrenalectomy sensitizes mice to the lethal effects of interleukin 1 and tumour necrosis factor. J Exp Med 1988;167:1708-12.
42. Harbuz MS, Chover-Gonzalez AJ, Biswas S et al. Role of central catecholamines in the modulation of corticotrophin-releasing factor mRNA during adjuvant-induced arthritis in the rat. Br J Rheumatol 1994;33:205-9.
43. Chowdrey HS, Larsen PJ, Harbuz MS et al. Endogenous substance P inhibits the expression of corticotropin-releasing hormone during a chronic inflammatory stress. Life Sci 1995;57:2021-9.
44. Sarlis NJ, Chowdrey HS, Stephanou A et al. Chronic activation of the hypothalamo-pituitary-adrenal axis and loss of circadian rhythm during adjuvant-induced arthritis in the rat. Endocrinology 1992;130:1775-9.